Literature DB >> 7980642

Antisense oligonucleotides to human lipocortin-1 inhibit glucocorticoid-induced inhibition of A549 cell growth and eicosanoid release.

J D Croxtall1, R J Flower.   

Abstract

Glucocorticoids actively inhibit the growth of A549 cells by suppressing the release of factors such as prostaglandin E2 (PGE2) necessary for their proliferation. This effect is largely mediated through induction of the protein lipocortin-1. We now show that transient transfection of A549 cells with an antisense DNA oligonucleotide targeted to a region coding the unique N-terminal portion of human lipocortin-1 blocks the induction of lipocortin-1 protein following glucocorticoid treatment and completely reverses glucocorticoid-induced suppression of cell proliferation and PGE2 release. A scrambled oligonucleotide was without effect. Continued culture of A549 cells in the presence of this oligonucleotide results in a sustained increase in cell proliferation and PGE2 release. This study reinforces the importance of lipocortin-1 as a negative modulator of cell growth and eicosanoid generation in this system.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7980642     DOI: 10.1016/0006-2952(94)90458-8

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  14 in total

1.  Glucocorticoids act within minutes to inhibit recruitment of signalling factors to activated EGF receptors through a receptor-dependent, transcription-independent mechanism.

Authors:  J D Croxtall; Q Choudhury; R J Flower
Journal:  Br J Pharmacol       Date:  2000-05       Impact factor: 8.739

Review 2.  Annexin A1: shifting the balance towards resolution and repair.

Authors:  Giovanna Leoni; Asma Nusrat
Journal:  Biol Chem       Date:  2016-10-01       Impact factor: 3.915

3.  Lack of annexin 1 results in an increase in corticotroph number in male but not female mice.

Authors:  J F Morris; S Omer; E Davies; E Wang; C John; T Afzal; S Wain; J C Buckingham; R J Flower; H C Christian
Journal:  J Neuroendocrinol       Date:  2006-11       Impact factor: 3.627

4.  Elevated levels of annexin I protein in vitro and in vivo in rat and human mammary adenocarcinoma.

Authors:  S D Pencil; M Toth
Journal:  Clin Exp Metastasis       Date:  1998-02       Impact factor: 5.150

5.  Antiallergic cromones inhibit neutrophil recruitment onto vascular endothelium via annexin-A1 mobilization.

Authors:  Samia Yazid; Giovanna Leoni; Stephen J Getting; Dianne Cooper; Egle Solito; Mauro Perretti; Roderick J Flower
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-06-17       Impact factor: 8.311

6.  Green tea inhibits cycolooxygenase-2 in non-small cell lung cancer cells through the induction of Annexin-1.

Authors:  Qing-Yi Lu; Yusheng Jin; Jenny T Mao; Zuo-Feng Zhang; David Heber; Steven M Dubinett; Jianyu Rao
Journal:  Biochem Biophys Res Commun       Date:  2012-10-02       Impact factor: 3.575

7.  Dexamethasone induces the secretion of annexin I in immature lymphoblastic cells by a calcium-dependent mechanism.

Authors:  M Castro-Caldas; C B Duarte; A P Carvalho; M C Fernandes Lopes
Journal:  Mol Cell Biochem       Date:  2002-08       Impact factor: 3.396

8.  Attenuation of glucocorticoid functions in an Anx-A1-/- cell line.

Authors:  Jamie D Croxtall; Derek W Gilroy; Egle Solito; Qamrul Choudhury; Barbara J Ward; Julia C Buckingham; Rod J Flower
Journal:  Biochem J       Date:  2003-05-01       Impact factor: 3.857

9.  Increased susceptibility of annexin-A1 null mice to nociceptive pain is indicative of a spinal antinociceptive action of annexin-A1.

Authors:  S S Ayoub; S Yazid; R J Flower
Journal:  Br J Pharmacol       Date:  2008-05-12       Impact factor: 8.739

10.  Cromoglycate drugs suppress eicosanoid generation in U937 cells by promoting the release of Anx-A1.

Authors:  Samia Yazid; Egle Solito; Helen Christian; Simon McArthur; Nicolas Goulding; Roderick Flower
Journal:  Biochem Pharmacol       Date:  2009-03-24       Impact factor: 5.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.